Home/ News & Events
Joint statement of solidarity and support
ESID is profoundly concerned about the grave repercussions of the conflict in Ukraine on PID community, healthcare and patients.
Together with IPOPI, INGID and J Project stakeholders, we have released a statement of solidarity and support to those impacted by the war in Ukraine.
Study on clinical course of IPEX patients infected with SARS-CoV-2
Call for international contributions relating to IPEX patients infected with SARS-CoV-2.
X-Linked Carrier Survey is now open
The Hyper IgM Foundation and the Wiskott-Aldrich Foundation’s first-ever international
X-Linked Carrier Surveys are now available! We are excited to launch this survey project in collaboration with the Primary Immune Deficiency Treatment Consortium (PIDTC) and the Immune Deficiency Foundation (IDF).
Independent study:SARS-CoV-2 infection in patients with GATA2 deficiencysurvey GATA2 Covid Docx, 128.96 kB Dear E...
Deciphering the immune response against human papillomavirus infection using imaging mass cytometryHuman papillomaviruses (HPVs) are responsible of approximately 5% of cancers worldwide, in particular cervical cancer in women. They are also responsible of recalcitrant warts, and devastating benign tumors such as Buschke-Lowenstein tumor and tree ma...
Independent Survey: SARS-CoV-2 infection in patients with IRAK-4 or MyD88 deficienciesDear ESID Member, We at ESID Board want to pay your immediate attention to an ongoing independent survey by the COVID Human Genetic Effort on the clinical characteristics of SARS-CoV-2 infection in patients with IRAK-4 or MyD88 deficiencies. We...
Joint statement on the current epidemics of new Coronavirus
Together with IPOPI, INGID, APSID, ASID, ARAPID, CIS, LASID, SEAPID we have worked on a joint statement to provide guidance in advising patients with primary immunodeficiency under our care in the current COVID-19 context.
SARS CoV2, COVID19 and PIDs - survey for clinicians
Dear colleagues, on behalf of the ESID Society we would like to ask for your input in this global initiative and to fill out the SARS CoV2, COVID19 and PIDs Survey for clinicians.